image credit: The Epoch Times / Flickr

Trump Signs $8.3B Coronavirus Measure to Fund Treatments, Labs, and Supplies

President Donald Trump this morning signed into law an $8.3 billion measure designed in part to fund the development of vaccines, therapies, and diagnostic tests for SARS-CoV-2—the virus at the center of the global COVID-19 outbreak.

The emergency supplemental appropriations measure, titled the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), will also fund construction or upgrades at labs involved in testing, developing vaccines or producing therapies—as well as cover the purchase of vaccines, tests, therapies, and necessary medical supplies for the Strategic National Stockpile.

Read More on Genetic Engineering and Biotechnology News